{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T11:15:17Z","timestamp":1783336517962,"version":"3.54.6"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,7]],"date-time":"2026-06-07T00:00:00Z","timestamp":1780790400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T00:00:00Z","timestamp":1783296000000},"content-version":"vor","delay-in-days":29,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100005317","name":"Kermanshah University of Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005317","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-56799-6","type":"journal-article","created":{"date-parts":[[2026,6,7]],"date-time":"2026-06-07T08:23:20Z","timestamp":1780820600000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Role of Nrf2 and NQO1 genetic variants in cardiometabolic diseases: an 8-year prospective study of genetic, dietary, biochemical, and oxidative stress markers in Iranian Kurdish Adults"],"prefix":"10.1038","volume":"16","author":[{"given":"Maryam","family":"Kohsari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Amiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehdi","family":"Moradinazar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kheirollah","family":"Yari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Davood","family":"Soleimani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ebrahim","family":"Shakiba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zohreh","family":"Rahimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,7]]},"reference":[{"key":"56799_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2024.105447","author":"T Eroglu","year":"2024","unstructured":"Eroglu, T., Capone, F. & Schiattarella, G. G. The evolving landscape of cardiometabolic diseases. EBioMedicine https:\/\/doi.org\/10.1016\/j.ebiom.2024.105447 (2024).","journal-title":"EBioMedicine"},{"key":"56799_CR2","doi-asserted-by":"publisher","DOI":"10.1093\/cvr\/cvae015","author":"T Chavakis","year":"2023","unstructured":"Chavakis, T., Cosentino, F. & Schmidt, A. M. Cardiometabolic disease: linking pathogenic mechanisms to therapeutic opportunities. Cardiovascular Research https:\/\/doi.org\/10.1093\/cvr\/cvae015 (2023).","journal-title":"Cardiovascular Research"},{"key":"56799_CR3","unstructured":"https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/obesity-and-overweight."},{"issue":"1","key":"56799_CR4","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s12944-021-01435-7","volume":"20","author":"R Akhigbe","year":"2021","unstructured":"Akhigbe, R. & Ajayi, A. The impact of reactive oxygen species in the development of cardiometabolic disorders: a review. Lipids in Health and Disease 2023. (2021).","journal-title":"Lipids in Health and Disease"},{"key":"56799_CR5","first-page":"1","volume":"24","author":"A Dehghani","year":"2024","unstructured":"Dehghani, A. et al. The prevalence of obesity and overweight among Iranian population: an umbrella systematic review and meta-analysis. BMC Public. Health Springer. 24, 1\u201327 (2024).","journal-title":"BMC Public. Health Springer"},{"key":"56799_CR6","first-page":"1322072","volume":"12","author":"N Hazar","year":"2024","unstructured":"Hazar, N., Jokar, M., Namavari, N., Hosseini, S. & Rahmanian, V. An updated systematic review and Meta-analysis of the prevalence of type 2 diabetes in Iran, 1996\u20132023. Frontiers in public health. Front. Media SA. 12, 1322072 (2024).","journal-title":"Front. Media SA"},{"key":"56799_CR7","first-page":"607","volume":"14","author":"S Mohammadi","year":"2023","unstructured":"Mohammadi, S. et al. Prevalence of hypertension in Iran: An updated systematic review and meta-analysis of community-based studies. Caspian J. Intern. Med. 14, 607 (2023).","journal-title":"Caspian J. Intern. Med."},{"key":"56799_CR8","doi-asserted-by":"publisher","first-page":"507","DOI":"10.3390\/antiox11030507","volume":"11","author":"C Zazueta","year":"2022","unstructured":"Zazueta, C., Jimenez-Uribe, A. P., Pedraza-Chaverri, J. & Buelna-Chontal, M. Genetic variations on redox control in cardiometabolic diseases: The role of Nrf2. Antioxidants 11, 507 (2022).","journal-title":"Antioxidants"},{"key":"56799_CR9","first-page":"1057918","volume":"13","author":"X Wu","year":"2022","unstructured":"Wu, X., Wei, J., Yi, Y., Gong, Q. & Gao, J. Activation of Nrf2 signaling: A key molecular mechanism of protection against cardiovascular diseases by natural products. Front. Media SA. 13, 1057918 (2022). Frontiers in pharmacology.","journal-title":"Front. Media SA"},{"key":"56799_CR10","first-page":"279","volume":"62","author":"L Torrente","year":"2022","unstructured":"Torrente, L. & DeNicola, G. M. Targeting NRF2 and its downstream processes: opportunities and challenges. Annual review of pharmacology and toxicology. Annual Reviews. 62, 279\u2013300 (2022).","journal-title":"Annual Reviews"},{"key":"56799_CR11","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1186\/s12885-019-6347-0","volume":"19","author":"Y Yamaguchi","year":"2019","unstructured":"Yamaguchi, Y. et al. Nrf2 gene mutation and single nucleotide polymorphism rs6721961 of the Nrf2 promoter region in renal cell cancer. BMC cancer Springer. 19, 1137 (2019).","journal-title":"BMC cancer Springer"},{"key":"56799_CR12","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.gene.2016.06.048","volume":"591","author":"Z Basharat","year":"2016","unstructured":"Basharat, Z., Messaoudi, A., Ruba, S. & Yasmin, A. NQO1 rs1800566 polymorph is more prone to NOx induced lung injury: Endorsing deleterious functionality through informatics approach. Gene Elsevier. 591, 14\u201320 (2016).","journal-title":"Gene Elsevier"},{"key":"56799_CR13","doi-asserted-by":"crossref","unstructured":"Ahmed, G. O. et al. The Correlation of Nrf2 rs6721961 Variants with the Risk of Type 2 Diabetes Mellitus and Obesity in Kurdistan of Iraq 26 (2022).","DOI":"10.5812\/jkums-131692"},{"key":"56799_CR14","doi-asserted-by":"publisher","first-page":"2009","DOI":"10.2337\/db21-1124","volume":"71","author":"C Jia","year":"2022","unstructured":"Jia, C. et al. NRF2 Genetic polymorphism modifies the association of plasma selenium levels with incident coronary heart disease among individuals with type 2 diabetes. Diabetes 71, 2009\u20132019 (2022).","journal-title":"Diabetes"},{"key":"56799_CR15","doi-asserted-by":"publisher","first-page":"16483","DOI":"10.3390\/ijms160716483","volume":"16","author":"X Wang","year":"2015","unstructured":"Wang, X. et al. Association between the NF-E2 related factor 2 gene polymorphism and oxidative stress, anti-oxidative status, and newly-diagnosed type 2 diabetes mellitus in a Chinese population. Int. J. Mol. Sci. 16, 16483\u201316496 (2015).","journal-title":"Int. J. Mol. Sci."},{"key":"56799_CR16","doi-asserted-by":"publisher","first-page":"9304383","DOI":"10.1155\/2022\/9304383","volume":"2022","author":"W Yu","year":"2022","unstructured":"Yu, W. et al. High level of uric acid promotes atherosclerosis by targeting NRF2-Mediated autophagy dysfunction and ferroptosis. Oxidative medicine and cellular longevity 2022, 9304383, 9304383. (2022).","journal-title":"Oxidative medicine and cellular longevity"},{"key":"56799_CR17","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1186\/s12902-022-00965-0","volume":"22","author":"TT Tao","year":"2022","unstructured":"Tao, T. T. et al. Association of genetic variants in the Sirt1 and Nrf2 genes with the risk of metabolic syndrome in a Chinese Han population. BMC Endocr. Disorders Springer. 22, 84 (2022).","journal-title":"BMC Endocr. Disorders Springer"},{"key":"56799_CR18","doi-asserted-by":"crossref","unstructured":"Keshani, M. et al. Mediterranean Diet Reduces Inflammation in Adults: A Systematic Review and Meta-analysis of Randomized Controlled Trials. Nutr. Rev.\u00a0nuaf213 (2025).","DOI":"10.1093\/nutrit\/nuaf213"},{"key":"56799_CR19","doi-asserted-by":"publisher","first-page":"2369674","DOI":"10.1155\/ijhy\/2369674","volume":"2025","author":"S Liweleya","year":"2025","unstructured":"Liweleya, S. et al. Mediterranean Diet as a Therapeutic Strategy for Hypertension and Cardiovascular Health. Int. J. Hypertens. Wiley Online Libr. 2025, 2369674 (2025).","journal-title":"Int. J. Hypertens. Wiley Online Libr."},{"key":"56799_CR20","doi-asserted-by":"publisher","first-page":"3617","DOI":"10.3390\/nu17223617","volume":"17","author":"E M\u0142ynarska","year":"2025","unstructured":"M\u0142ynarska, E. et al. The Mediterranean Diet in Primary and Secondary Prevention of Coronary Heart Disease: Evidence and Mechanisms. Nutrients MDPI. 17, 3617 (2025).","journal-title":"Nutrients MDPI"},{"key":"56799_CR21","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1093\/ije\/dyy296","volume":"48","author":"Y Pasdar","year":"2019","unstructured":"Pasdar, Y. et al. Cohort profile: Ravansar Non-Communicable Disease cohort study: the first cohort study in a Kurdish population. International journal of epidemiology 48, 682\u2013683f (2019).","journal-title":"International journal of epidemiology"},{"key":"56799_CR22","doi-asserted-by":"crossref","unstructured":"Association, A. D. 2. Classification and diagnosis of diabetes: standards of medical care in diabetes\u20142018. Diabetes care\u00a041, S13\u201327 (2018).","DOI":"10.2337\/dc18-S002"},{"key":"56799_CR23","first-page":"1059870","volume":"10","author":"S Eghtesad","year":"2023","unstructured":"Eghtesad, S. et al. Validity and reproducibility of a food frequency questionnaire assessing food group intake in the PERSIAN Cohort Study. Frontiers in nutrition. Front. Media SA. 10, 1059870 (2023).","journal-title":"Front. Media SA"},{"key":"56799_CR24","doi-asserted-by":"crossref","unstructured":"Qaisar, S. A. et al. Association between dietary quality index\u2013international (DQI-I) and fatty liver indices: results from the Ravansar non-communicable disease (RaNCD) cohort study. Scientific Reports\u00a0(2025).","DOI":"10.1038\/s41598-025-27198-0"},{"key":"56799_CR25","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.b2337","author":"A Trichopoulou","year":"2009","unstructured":"Trichopoulou, A., Bamia, C. & Trichopoulos, D. Anatomy of health effects of Mediterranean diet: Greek EPIC prospective cohort study. BMJ https:\/\/doi.org\/10.1136\/bmj.b2337 (2009).","journal-title":"BMJ"},{"key":"56799_CR26","doi-asserted-by":"publisher","first-page":"1188","DOI":"10.3945\/ajcn.114.089706","volume":"100","author":"N Roswall","year":"2014","unstructured":"Roswall, N. et al. Association between Mediterranean and Nordic diet scores and changes in weight and waist circumference: influence of FTO and TCF7L2 loci. Am. J. Clin. Nutr. 100, 1188\u20131197 (2014).","journal-title":"Am. J. Clin. Nutr."},{"issue":"1","key":"56799_CR27","doi-asserted-by":"publisher","first-page":"12409","DOI":"10.1038\/s41598-019-48232-y","volume":"9","author":"F Rajati","year":"2019","unstructured":"Rajati, F. et al. Prevalence, awareness, treatment, and control of hypertension and their determinants: Results from the first cohort of non-communicable diseases in a Kurdish settlement. Scientific Reports 912409. (2019).","journal-title":"Scientific Reports"},{"key":"56799_CR28","doi-asserted-by":"publisher","first-page":"80","DOI":"10.4103\/2322-1232.222550","volume":"3","author":"MT Moradi","year":"2014","unstructured":"Moradi, M. T., Yari, K. & Khodarahmi, R. A novel, efficient, fast and inexpensive DNA extraction protocol from whole blood applicable for studying drug-DNA interaction. J. Rep. Pharm. Sci. 3, 80\u201384 (2014).","journal-title":"J. Rep. Pharm. Sci."},{"key":"56799_CR29","doi-asserted-by":"publisher","first-page":"101955","DOI":"10.1016\/j.pmedr.2022.101955","volume":"29","author":"L Tussing-Humphreys","year":"2022","unstructured":"Tussing-Humphreys, L. et al. Effect of Mediterranean diet and Mediterranean diet plus calorie restriction on cognition, lifestyle, and cardiometabolic health: a randomized clinical trial. Prev. Med. Rep. 29, 101955 (2022).","journal-title":"Prev. Med. Rep."},{"key":"56799_CR30","doi-asserted-by":"publisher","first-page":"661","DOI":"10.3945\/jn.116.245431","volume":"147","author":"J Mattei","year":"2017","unstructured":"Mattei, J., Sotos-Prieto, M., Bigornia, S. J., Noel, S. E. & Tucker, K. L. The Mediterranean diet score is more strongly associated with favorable cardiometabolic risk factors over 2 years than other diet quality indexes in Puerto Rican adults. J. Nutr. 147, 661\u2013669 (2017).","journal-title":"J. Nutr."},{"key":"56799_CR31","doi-asserted-by":"publisher","first-page":"261","DOI":"10.17816\/ecogen562714","volume":"21","author":"MA Shkurat","year":"2023","unstructured":"Shkurat, M. A., Mashkina, E. V., Milyutina, N. P. & Shkurat, T. P. The role of polymorphism of redox-sensitive genes in the mechanisms of oxidative stress in obesity and metabolic diseases. Ecol. Genet. 21, 261\u2013287 (2023).","journal-title":"Ecol. Genet."},{"key":"56799_CR32","doi-asserted-by":"publisher","first-page":"2067","DOI":"10.3390\/antiox11102067","volume":"11","author":"Y Xia","year":"2022","unstructured":"Xia, Y., Zhai, X., Qiu, Y., Lu, X. & Jiao, Y. The Nrf2 in obesity: A friend or foe?. Antioxidants 11, 2067 (2022).","journal-title":"Antioxidants"},{"key":"56799_CR33","doi-asserted-by":"publisher","first-page":"235","DOI":"10.3390\/antiox11020235","volume":"11","author":"J Guti\u00e9rrez-Cuevas","year":"2022","unstructured":"Guti\u00e9rrez-Cuevas, J. et al. The role of NRF2 in obesity-associated cardiovascular risk factors. Antioxidants 11, 235 (2022).","journal-title":"Antioxidants"},{"key":"56799_CR34","doi-asserted-by":"publisher","first-page":"100585","DOI":"10.1016\/j.obmed.2025.100585","volume":"2025","author":"DE Uti","year":"2025","unstructured":"Uti, D. E. et al. Cytokines as key players in obesity low grade inflammation and related complications. Obesity Med. 2025, 100585 (2025).","journal-title":"Obesity Med."},{"key":"56799_CR35","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.cotox.2017.11.002","volume":"7","author":"K Lingappan","year":"2018","unstructured":"Lingappan, K. NF-\u03baB in oxidative stress. Current Opin. Toxicol. 7, 81\u201386 (2018).","journal-title":"Current Opin. Toxicol."},{"key":"56799_CR36","doi-asserted-by":"publisher","first-page":"1368765","DOI":"10.3389\/fphar.2024.1368765","volume":"15","author":"M Ding","year":"2024","unstructured":"Ding, M. et al. Potential mechanisms of formononetin against inflammation and oxidative stress: A review. Front. Pharmacol. 15, 1368765 (2024).","journal-title":"Front. Pharmacol."},{"key":"56799_CR37","doi-asserted-by":"publisher","first-page":"101950","DOI":"10.1016\/j.redox.2021.101950","volume":"41","author":"D Ross","year":"2021","unstructured":"Ross, D. & Siegel, D. The diverse functionality of NQO1 and its roles in redox control. Redox Biology 41, 101950, 101950. (2021).","journal-title":"Redox Biology"},{"key":"56799_CR38","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.tem.2020.11.002","volume":"32","author":"S Baumel-Alterzon","year":"2021","unstructured":"Baumel-Alterzon, S., Katz, L. S., Brill, G., Garcia-Oca\u00f1a, A. & Scott, D. K. Nrf2: the master and captain of beta cell fate. Trends Endocrinol. Metabolism 32, 7\u201319 (2021).","journal-title":"Trends Endocrinol. Metabolism"},{"issue":"1","key":"56799_CR39","doi-asserted-by":"publisher","first-page":"7367641","DOI":"10.1155\/2016\/7367641","volume":"2016","author":"AS Jim\u00e9nez-Osorio","year":"2016","unstructured":"Jim\u00e9nez-Osorio, A. S. et al. Association of nuclear factor-erythroid 2\u2010related factor 2, thioredoxin interacting protein, and heme oxygenase\u20101 gene polymorphisms with diabetes and obesity in Mexican patients. Oxidative Medicine and Cellular Longevity 2016 7367641. (2016).","journal-title":"Oxidative Medicine and Cellular Longevity"},{"key":"56799_CR40","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0123313","volume":"10","author":"A Mart\u00ednez-Hern\u00e1ndez","year":"2015","unstructured":"Mart\u00ednez-Hern\u00e1ndez, A. et al. Association of HMOX1 and NQO1 polymorphisms with metabolic syndrome components. PLOS ONE 10, e0123313 (2015).","journal-title":"PLOS ONE"},{"key":"56799_CR41","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1007\/s11010-011-1098-5","volume":"361","author":"T Ramprasath","year":"2012","unstructured":"Ramprasath, T. et al. Genetic association of Glutathione peroxidase-1 (GPx-1) and NAD (P) H: Quinone Oxidoreductase 1 (NQO1) variants and their association of CAD in patients with type-2 diabetes. Mol. Cellular Biochem. 361, 143\u2013150 (2012).","journal-title":"Mol. Cellular Biochem."},{"key":"56799_CR42","doi-asserted-by":"publisher","first-page":"22559","DOI":"10.1074\/jbc.M101053200","volume":"276","author":"A Gaikwad","year":"2001","unstructured":"Gaikwad, A., Long, D. J., Stringer, J. L. & Jaiswal, A. K. In vivo role of NAD (P) H: quinone oxidoreductase 1 (NQO1) in the regulation of intracellular redox state and accumulation of abdominal adipose tissue. J. Biol. Chem. 276, 22559\u201322564 (2001).","journal-title":"J. Biol. Chem."},{"key":"56799_CR43","doi-asserted-by":"publisher","first-page":"325","DOI":"10.7150\/ijms.14849","volume":"13","author":"T Kunnas","year":"2016","unstructured":"Kunnas, T., M\u00e4\u00e4tt\u00e4, K. & Nikkari, S. T. Genetic polymorphisms of transcription factor NRF2 and of its host gene sulfiredoxin (SRXN1) are associated with cerebrovascular disease in a Finnish cohort, the TAMRISK study. Int. J. Med. Sci. 13, 325 (2016).","journal-title":"Int. J. Med. Sci."},{"issue":"1","key":"56799_CR44","doi-asserted-by":"publisher","first-page":"9237263","DOI":"10.1155\/2017\/9237263","volume":"2017","author":"S Satta","year":"2017","unstructured":"Satta, S., Mahmoud, A. M., Wilkinson, F. L., Alexander, Y. & White, S. J. The role of Nrf2 in cardiovascular function and disease. Oxidative Medicine and Cellular Longevity 20179237263. (2017).","journal-title":"Oxidative Medicine and Cellular Longevity"},{"key":"56799_CR45","first-page":"S1","volume":"65","author":"M Barancik","year":"2016","unstructured":"Barancik, M., Gresova, L., Bartekov\u00e1, M. & Dovinov\u00e1, I. Nrf2 as a key player of redox regulation in cardiovascular diseases. Physiological Research. Institute of Physiology 65, S1 (2016).","journal-title":"Physiological Research. Institute of Physiology"},{"key":"56799_CR46","doi-asserted-by":"publisher","first-page":"13345","DOI":"10.3390\/ijms241713345","volume":"24","author":"N Wakabayashi","year":"2023","unstructured":"Wakabayashi, N., Yagishita, Y., Joshi, T. & Kensler, T. W. Forced hepatic expression of NRF2 or NQO1 impedes hepatocyte lipid accumulation in a lipodystrophy mouse model. Int. J. Mol. Sci. MDPI. 24, 13345 (2023).","journal-title":"Int. J. Mol. Sci. MDPI"},{"key":"56799_CR47","doi-asserted-by":"publisher","first-page":"102084","DOI":"10.1016\/j.cpcardiol.2023.102084","volume":"49","author":"SU Khan","year":"2024","unstructured":"Khan, S. U. et al. Natural allies for heart health: Nrf2 activation and cardiovascular disease management. Curr. Probl. Cardiol. Elsevier. 49, 102084 (2024).","journal-title":"Curr. Probl. Cardiol. Elsevier"},{"key":"56799_CR48","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1158\/0008-5472.CAN-06-2401","volume":"67","author":"Y-J Kim","year":"2007","unstructured":"Kim, Y.-J. et al. Human prx1 gene is a target of Nrf2 and is up-regulated by hypoxia\/reoxygenation: implication to tumor biology. Cancer Res. 67, 546\u201354 (2007).","journal-title":"Cancer Res."},{"key":"56799_CR49","doi-asserted-by":"publisher","first-page":"e3791","DOI":"10.1371\/journal.pone.0003791","volume":"3","author":"TE Sussan","year":"2008","unstructured":"Sussan, T. E. et al. Disruption of Nrf2, a key inducer of antioxidant defenses, attenuates ApoE-mediated atherosclerosis in mice. PloS one. 3, e3791 (2008).","journal-title":"PloS one."},{"key":"56799_CR50","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1161\/01.RES.0000119171.44657.45","volume":"94","author":"T Ishii","year":"2004","unstructured":"Ishii, T. et al. Role of Nrf2 in the regulation of CD36 and stress protein expression in murine macrophages: activation by oxidatively modified LDL and 4-hydroxynonenal. Circulation Res. 94, 609\u201316 (2004).","journal-title":"Circulation Res."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-56799-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-56799-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-56799-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T10:20:43Z","timestamp":1783333243000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-56799-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,7]]},"references-count":50,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["56799"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-56799-6","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,7]]},"assertion":[{"value":"20 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"We confirm that all methods relevant to human participants were performed in accordance with the Declaration of Helsinki and approved by the research ethics committee of Kermanshah University of Medical Sciences (Ethics code: IR.KUMS.MED.REC.1402.328). The study protocol was fully explained to all participants, and each individual provided written informed consent to participate in the research.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"20764"}}